Matthew Stanton
Stock Analyst at Jefferies
(0.25)
# 4,060
Out of 4,784 analysts
5
Total ratings
33.33%
Success rate
-26.72%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $6.09 | +31.36% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.14 | +185.09% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $25.96 | -15.25% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $34.61 | +84.92% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $6.09
Upside: +31.36%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.14
Upside: +185.09%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $25.96
Upside: -15.25%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $34.61
Upside: +84.92%